Poster Abstracts & Grand Rounds Case Submissions

Read all of the following guidelines before submission.
The pre-submission agreement is required before a poster or Grand Rounds submission.

Important Information:

  • January 09, 2009 (Midnight CST) - Deadline for Submitting poster abstracts and Aeromedical grand rounds submissions. No late submissions will be accepted.
  • January 16, 2009 - Poster & Aeromedical Grand Rounds presenters will be notified.
  • Poster Presenters: Make Posters 4'X6' and have 8.5"X11" (letter) sized copies of your posters available to hand out. The presenters are requested to be at their Posters during the Poster Sessions to discuss their findings.
  • Grand Rounds Presenters: Format is 15-minute case presentations which highlight an Aeromedical decision-making process. Followed by a 5-minute Q&A. Presentations should include standard clinical case discussions followed by a brief discussion of Aeromedical decision-making and implications involved in the case.

Introduction

The members of the Program Committee and Panel Reviewers grade approximately 50-75 poster abstracts for each conference. Abstracts and Grand Rounds Submissions are blinded to the reviewer. The Program Chair/Committee exercises some discretion in final selections in an attempt to balance the program. Submissions are graded on a 0 to 10 rating, with an average weighted score of 7.0. MICE reserves the right to withdraw any submission at any time.

Aeromedical Grand Rounds Submissions

This year MICE is proud to offer Aeromedical Rounds submissions!!! Format is 15-minute case presentations which highlight an Aeromedical decision-making process. Followed by a 5-minute Q&A. Presentations should include standard clinical case discussions followed by a brief discussion of Aeromedical decision-making and implications involved in the case. Presentations may be made by an individual or as a team.

Poster/Grand Rounds Content

Submissions must adequately describe the objectives and results of the work so that the quality, originality, and thoroughness can be evaluated by the Program Committee.


Each submission MUST be less than 650 words and include the following components:

  • Title
  • Author's Name - Include rank and/or credentials
  • Institution (Ex: University or Duty Base with City and State)
  • Co-Author's Name - Include rank and/or credentials
  • Objectives - An introductory sentence indicating the purpose of the study
  • Methods - A brief description of pertinent experimental procedures
  • Results - A summary of the NEW, UNPUBLISHED DATA
  • Conclusion - A statement of the conclusions
Submission missing any of the above items (with the exception of Co-Authors) WILL NOT BE CONSIDERED Graphs, Pictures, ect. are not permitted. Submissions may be copied and pasted into the web form.

Criteria To Consider When Submitting An Abstract

Within the character count abstracts should:

  • Use title and key words appropriately
  • Indicate any potential conflict(s) of interest
  • Represent original research
  • Represent a significant issue
  • Be well organized and include Objectives, Methods, Results, and Conclusions
    • Include an Objective that:
      • Is simple and clear
      • Clarifies the importance of the study
    • Include a Method that:
      • Is reproducible
      • Avoids irrelevant data
      • Describes sample with sufficient detail so that it is clear what population(s) the sample represents
      • Describes how the sample is of adequate size
      • Describes how sample was formed to avoid biases
      • Describes pretested unambiguous instruments and materials, including all surveys, tests, questionnaires, interview forms, and other tools used to provide data
      • Includes controls and clarifies them, with evidence of reliability and validity
      • Includes well-defined criteria for evaluation of variables.
      • Describes procedures, whether or not the study is prospective randomized, and researcher activities
    • Include Results that:
      • Summarize, including techniques and analysis used, including appropriate power analysis
      • Include complications or missing data, if applicable
      • Include validated outcomes
    • Include a Conclusion that:
      • Follows from methods
      • Includes discussion of limitations, if applicable
      • Recognizes limitations of study and suggests new research needed to extend current findings

Pre-Submission Agreement

All authors must agree to the following statements before this poster abstract or grand rounds case can be submitted. You must read through and click the "ACCEPT" button in order to submit a poster abstract or grand rounds case.

We, the listed authors on this abstract or case, submit this poster abstract or case for presentation consideration to MICE. We affirm that the information contained in this poster or case abstract fairly and accurately represents original work.

We assume full responsibility for securing the necessary clearance and permission for publication and presentation from any contracting supervisory research agency holding presentation material copyrights.

We agree that any and all financial interests in the product or process involved with our research will be properly identified. This includes stock ownership, membership on an advisory board or board of directors, corporate sponsored research, or any other substantive relationship. Please note that financial disclosure does not disqualify a poster abstract or case from consideration or presentation.

Please review your submission carefully as all approved poster and case presenters will have their poster or case listed in the program book as submitted. Poster and case presenters by accepting terms consent to their poster or case being published in the 2009 program book.

We agree that disclosure will be made if a presentation includes substances or products not approved in the U.S. for the use under discussion.



Abstract Submission deadline is Over.

Co-Sponsored by:
TRUE
RESEARCH FOUNDATION
Best viewed with
Resolution: 800x600+